Approval · Notice of Compliance 8671 · 2007
ANDROCUR: Notice of Compliance 8671
Issued March 26, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8671
- Date
- March 26, 2007
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiandrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDROCUR | 00704431 | Marketed |
| ANDROCUR DEPOT | 00704423 | Cancelled Post Market |
Medicinal ingredients
- CYPROTERONE ACETATE 50 MG per TAB
- CYPROTERONE ACETATE 100 MG per ML